While both MDMA and psilocybin show promise for hard-to-treat psychiatric disorders, it’s important to keep in mind that the conditions in these studies were strictly controlled and the patients meticulously monitored during treatment. Once approved, MAPS says the drug will be administered in an inpatient setting at DEA-certified clinics by licensed therapists who have been…
My take? If Dr. Gottlieb’s statement were a pharmacology graduate student’s written qualifying exam answer to a question seeking an objective assessment of kratom pharmacology and toxicology, I’d have no choice but to issue a failing grade … I say this all with great respect for Dr. Gottlieb, a physician and former Forbes contributor, 1. You failed…
For years, [cannabis] convictions have had painful implications on the everyday lives of Washington’s most vulnerable populations, Mayor Jenny Durkan said in a press conference Thursday, Feb. 8th, 2018. Durkan said she hoped Seattle’s plan will serve as a template for other cities seeking to correct the biases of outdated and punitive drug laws. “It…
FDA officials have recommended kratom be categorized as a Schedule 1 drug, which would effectively mean that scientists would not be able to study its effects …“The problem with saying it’s ‘an opioid’ without qualification is that it just paints everything with this broad brush, and obviously carries a negative connotation given what’s going on…
With the opioid crisis claiming hundreds of lives each week, why would the government list this promising plant as a Schedule 1, making research and testing nearly impossible? Whom is the FDA trying to protect — the public or Big Pharma, which loses profits when citizens find a safe, natural, inexpensive alternative to addictive opioids?…
Anti-kratom activists, led by FDA Commissioner Scott Gottlieb, are committed to protecting the opioid manufacturers who are raking in billions of dollars every year by hooking honest Americans who are trying to manage chronic pain on highly addictive and potentially deadly opioids. I am not going to mince words, I am frustrated. There is no…
Just one of the FDA’s cases appears to involve the presence of kratom alone, though the report includes no information on the death apart from the subject’s age and ethnicity. The report shows the individual tested positive for high levels of mitragynine [which is a industrialized and processed extract of the Kratom plant, distinct from…
“It’s a unique plant that deserves to remain legal,” Brockler said. “It was green Kratom that I started with,” said Emily Szarak, a user of the supplement. “That has been a lifesaver. I feel like a human again.” Szarak [said] she turned to Kratom after years of taking prescription pills to treat chronic pain. Original…
*tax-payer funded DEA offices The medical potential of kratom is widely unknown. Plants are rarely studied for medical use in the United States, which is why there is never “enough research” to determine whether or not doctors can refer to them as “safe and effective” and recommend their use. The “active ingredient” in kratom is…
*Bayer (one of the corporations who actively lobbied the DEA in 2017 demonstrate their Xpro fungacide product at a demonstration) Total Number of Clients: 24 Bayer AG Corp lobbied the DEA in 2017. Original Article (Opensecrets):Annual number of clients lobbying the Drug Enforcement Administration (DEA)Artwork Fair Use: Michael Trolove
Recent Comments